Stock SYNGENE SYNGENE INTERNATIONAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Syngene International Limited Bombay S.E.

Equities

SYNGENE

INE398R01022

Biotechnology & Medical Research

Market Closed - Bombay S.E.
Other stock markets
 06:00:49 2024-04-25 am EDT 		5-day change 1st Jan Change
699 INR +0.68% Intraday chart for Syngene International Limited -1.57% -0.31%
Apr. 24 Syngene International Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Apr. 12 INDIA STOCKS-Financials drag Indian shares, hit by fading US rate cut hopes RE

Business Summary

Syngene International Limited is an integrated research, development, and manufacturing services company. The Company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) manufacturing, formulation, and analytical development, along with clinical development services. It offers SynVent, a therapeutic discovery and development platform for executing drug discovery projects. SynVent's portfolio covers modalities and therapeutic areas ranging from small molecule inhibitors to targeted protein stabilization. It serves the pharmaceutical, biotechnology, and specialty chemical sectors, among others. It operates multi-modal biologics manufacturing facility.

Number of employees: 6,847

Sales per Business

INR in Million2022Weight2023Weight Delta
Contract Research and Manufacturing Services
96.5 %
25,067 96.3 % 30,802 96.5 % +22.88%
Others
3.4 %
953 3.7 % 1,077 3.4 % +13.01%
Scrap
0.2 %
22 0.1 % 50 0.2 % +127.27%

Sales per region

INR in Million2022Weight2023Weight Delta
United States
71.8 %
18,782 72.1 % 22,918 71.8 % +22.02%
Europe
17.9 %
-- 5,711 17.9 % -
Rest of the World
6.5 %
4,471 17.2 % 2,083 6.5 % -53.41%
India
3.8 %
2,789 10.7 % 1,217 3.8 % -56.36%

Managers

Managers TitleAgeSince
Jonathan Hunt CEO
 Chief Executive Officer 55 15-02-28
Sibaji Biswas DFI
 Director of Finance/CFO - 19-12-17
Kiran Mazumdar-Shaw CHM
 Chairman 71 94-11-17
Priyadarshini I. Mahapatra CMP
 Compliance Officer - 19-07-23
Krishnan G. IRC
 Investor Relations Contact - 20-04-30
Andrew Webster HRO
 Human Resources Officer - 22-11-30
Alok Mehrotra PRN
 Corporate Officer/Principal - -
Caroline Hempstead PRN
 Corporate Officer/Principal - 18-12-31

Members of the board

Members of the board TitleAgeSince
Kiran Mazumdar-Shaw CHM
 Chairman 71 94-11-17
Vinita Kundanlal Bali BRD
 Director/Board Member 67 17-07-30
Jonathan Hunt CEO
 Chief Executive Officer 55 15-02-28
Kush Parmar BRD
 Director/Board Member 42 21-06-21
Paul Blackburn BRD
 Director/Board Member 70 14-08-25
Catherine Rosenberg BRD
 Director/Board Member 62 00-08-07
Vijay Kumar Kuchroo BRD
 Director/Board Member 68 17-02-28
Sharmila Abhay Karve BRD
 Director/Board Member 59 19-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 402,536,981 179,209,196 ( 44.52 %) 1,243,697 ( 0.3090 %) 44.52 %

Shareholders

NameEquities%Valuation
BIOCON LIMITED
54.52 %
219,185,608 54.52 % 1 844 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
2.907 %
11,687,932 2.907 % 98 M ₹
Norges Bank Investment Management
1.749 %
7,031,718 1.749 % 59 M ₹
Mirae Asset Investment Managers (India) Pvt Ltd.
1.214 %
4,882,044 1.214 % 41 M ₹
Kotak Mahindra Asset Management (Singapore) Pte Ltd.
0.9985 %
4,013,948 0.9985 % 34 M ₹
PGIM India Asset Management Pvt Ltd.
0.8170 %
3,284,529 0.8170 % 28 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
0.6687 %
2,688,196 0.6687 % 23 M ₹
Edelweiss Asset Management Ltd.
0.4703 %
1,890,756 0.4703 % 16 M ₹
HSBC Asset Management (India) Pvt Ltd.
0.4572 %
1,837,998 0.4572 % 15 M ₹
White Oak Capital Partners Pte Ltd.
0.4390 %
1,764,890 0.4390 % 15 M ₹

Company contact information

Syngene International Ltd.

Biocon Park, Biocon SEZ Bommasandra Indl Area, IV Phase

560099, Bangalore

+91 80 6891 9191

http://www.syngeneintl.com
address Syngene International Limited(SYNGENE)

Group companies

NameCategory and Sector
Syngene Scientific Solutions Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Ratings for Syngene International Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
699.1 INR
Average target price
761.4 INR
Spread / Average Target
+8.91%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.83% 43.84B
MODERNA, INC. Stock Moderna, Inc.
+5.44% 41.68B
LONZA GROUP AG Stock Lonza Group AG
+45.26% 41.25B
CELLTRION, INC. Stock Celltrion, Inc.
-11.96% 27.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.98% 25.53B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.08% 18.18B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.49% 12.29B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.16% 12.29B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.63% 11.15B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. SYNGENE Stock
  4. SYNGENE Stock
  5. Company Syngene International Limited